Biomarkers in the Drug Development Process
Venue: NH Barbizon Palace
|Event Date/Time: Nov 21, 2007||End Date/Time: Nov 22, 2007|
Presentations will also include examples of organ specific safety biomarkers: challenges in discovery, development and registration, as well as for clinical efficacy biomarkers in different biological fluids. A special presentation has been added on the latest developments in the use of epigenetic for cancer therapy.
In the workshop an update will be provided on the US C-Path Initiative (www.c-path.org) and on the European Innovative Medicines Initiative (www.imi-europe.org). The US and European regulatory view on acceptance of novel biomarkers will be presented and discussed by a panel.